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Abstract
Background: More than 50 percent of all infants born very preterm will experience significant motor and
cognitive impairment. Provision of early intervention is dependent upon accurate, early identification of infants
at risk of adverse outcomes. Magnetic resonance imaging at term equivalent age combined with General
Movements assessment at 12 weeks corrected age is currently the most accurate method for early prediction of
cerebral palsy at 12 months corrected age. To date no studies have compared the use of earlier magnetic
resonance imaging combined with neuromotor and neurobehavioural assessments (at 30 weeks postmenstrual
age) to predict later motor and neurodevelopmental outcomes including cerebral palsy (at 12–24 months
corrected age). This study aims to investigate i) the relationship between earlier brain imaging and neuromotor/
neurobehavioural assessments at 30 and 40 weeks postmenstrual age, and ii) their ability to predict motor and
neurodevelopmental outcomes at 3 and 12 months corrected age.
Methods/design: This prospective cohort study will recruit 80 preterm infants born ≤30 week’s gestation and a
reference group of 20 healthy term born infants from the Royal Brisbane & Women’s Hospital in Brisbane,
Australia. Infants will undergo brain magnetic resonance imaging at approximately 30 and 40 weeks
postmenstrual age to develop our understanding of very early brain structure at 30 weeks and maturation that
occurs between 30 and 40 weeks postmenstrual age. A combination of neurological (Hammersmith Neonatal
Neurologic Examination), neuromotor (General Movements, Test of Infant Motor Performance), neurobehavioural
(NICU Network Neurobehavioural Scale, Premie-Neuro) and visual assessments will be performed at 30 and
40 weeks postmenstrual age to improve our understanding of the relationship between brain structure and
function. These data will be compared to motor assessments at 12 weeks corrected age and motor and
neurodevelopmental outcomes at 12 months corrected age (neurological assessment by paediatrician, Bayley
scales of Infant and Toddler Development, Alberta Infant Motor Scale, Neurosensory Motor Developmental
Assessment) to differentiate atypical development (including cerebral palsy and/or motor delay).
Discussion: Earlier identification of those very preterm infants at risk of adverse neurodevelopmental and motor
outcomes provides an additional period for intervention to optimise outcomes.
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Background
Infants born very preterm (<32 weeks gestational age;
GA) are at a high risk of experiencing significant motor
difficulties with 10–15 % developing cerebral palsy
(CP) [1], a further 40–50 % having minor motor and
behavioural difficulties [2, 3] and 30–60 % experiencing
cognitive difficulties at school age [4]. At least 25 % of
infants follow a trajectory of typical development with
no evident sequelae of their difficult neonatal course
[5]. Interventions are becoming available which aim to
improve outcomes for infants born very preterm, ne-
cessitating the development of tools which can firstly
identify those infants at risk of adverse outcomes as
early as possible, and secondly provide accurate quanti-
tative measurement of changes that are the result of an
intervention. Currently, brain Magnetic Resonance Im-
aging (MRI) at term equivalent age (TEA) combined
with the General Movements assessment (GMs) at
3 months corrected age (CA), show the greatest pre-
dictive accuracy of motor and neurodevelopmental out-
comes and CP at 1, 2 and 5 years CA [6–10].
In preterm infants imaged at TEA, structural MRI (T1
and T2 weighted images) analysed qualitatively for evi-
dence of white and grey matter abnormalities predict
motor and cognitive outcome [8, 11], motor distribution
of CP [12, 13], severity of motor involvement in CP [14]
and neurobehavioural development [15]. White matter
injury has been identified as the predominant injury in the
preterm infant brain, with lesions such as periventricular
leukomalacia (PVL) and intra-ventricular haemorrhage
(IVH) well described and linked to poorer outcomes and
CP [8, 16]. More recently, recognition of the intercur-
rent and subsequent developmental disturbances in
both white and grey matter as a result of the primary
lesion, support the description of preterm brain injury
as an ‘encephalopathy of prematurity’ [17]. Qualitative
classification of grey and white matter macrostructure
from structural MRI has improved prediction of out-
comes, but the need for quantitative microstructural
information has lead to investigation of diffusion MRI
in this population [18, 19].
Diffusion MRI measures the random motion of water
molecules, which is hindered and restricted by the pres-
ence of cell membranes, the cytoskeleton, and macromol-
ecules in the brain [20]. A number of quantitative metrics
can be obtained from diffusion MRI to characterise the
tissue, including fractional anisotropy (FA), mean diffusiv-
ity (MD), axial diffusivity (AD), and radial diffusivity (RD)
derived using the diffusion tensor model (i.e. Diffusion
Tensor Imaging, DTI) [21]. These measures of the degree
of restriction of diffusion (FA) and speed of diffusion
(MD) change during brain development due to increasing
fibre organisation, membrane proliferation, and myelin-
ation [22]. Diffusion MRI also provides estimates for the
direction of the underlying white matter tracts, and, using
tractography, enables the delineation of those pathways as
they course through the brain.
White matter damage of prematurity is associated with
increased values of MD and decreased values of FA [22, 23].
A significant correlation exists between values of FA in the
corticospinal tracts and postmenstrual age (PMA) [24] and
between MD and later motor impairment [25]. Higher MD
values at term are associated with poorer neurodevelopmen-
tal outcomes at 2 years in preterm infants [26]. Diffusion
MRI has been reported to be an independent predictor of
psychomotor delay [25] and to predict CP with a sensitivity
of 80 % (95 % Confidence Interval [CI] 28–100) and a speci-
ficity of 66 % (95 % CI 53–78) [25]. Associations between FA
values and cognitive outcomes have been reported [27]. The
use of MRI tractography to predict neurodevelopmental out-
comes is not yet well established [28].
Potential limitations of diffusion imaging such as
complex crossing fibre microstructure, reliability and
reproducibility, are being addressed through novel dif-
fusion MRI acquisition and analysis techniques [29].
Customized for preterm babies, they include novel pre-
processing, the use of 60-direction High Angular Reso-
lution Diffusion Imaging (HARDI), high b values and
fibre orientation distribution analysis [30]. These deal
with the identified need for greater accuracy of tracto-
graphy and improved quantitative markers [31].
Imaging technology advances are now able to be
coupled with earlier imaging, with the advent of MRI
compatible incubators. Safety and feasibility have been
established for MRI in the neonatal period after birth and
before TEA, with the potential to provide further insights
into this period of rapid brain development [32–37]. At
the stage very preterm infants enter the extra-uterine en-
vironment, between the end of the second and beginning
of the third trimesters, cortical neurogenesis and
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migration are complete, axonal and dendritic branching
continue vigorously, and synaptogenesis is commencing
[38, 39]. From this stage until TEA is reached, white mat-
ter increases by 5 times the original volume, cortical grey
matter volume increases 4 times and cortical folding both
commences and is essentially completed [15, 40]. Brain
development is rapid, vulnerable to injury but also adap-
tive to environmental inputs that guide and consolidate
developing brain connections in a process termed neuro-
plasticity [41].
An area of specific interest in early imaging is the cor-
tical subplate [42]. This structure consists of neurons
formed in deep grey matter neurogenic sites such as the
thalamus, and arrive to lie below the cortical neurons
that migrated earlier from the subventricular zone [43].
At 30 weeks gestation, the subplate reaches its peak
thickness, many times thicker than the cortex, and by
term has almost completely regressed [44]. This major
wave of growth and death establishes the long range
projections between the deep grey matter and the cor-
tex, and the short- and long- range cortico-cortical con-
nections that are fundamental to integration of motor
and cognitive functions [45]. This information on brain
structure and structural connectivity from earlier neuro-
imaging increases the potential of understanding the
trajectory of structural brain development.
Electroencephalography (EEG) is a useful method of
measuring cortical function for diagnosis and predict-
ing later outcomes. Relationships between EEG and
structural and functional connectivity have been shown
throughout development in both adults and infants
[46–50]. Electroencephalography signals represent cor-
tical electrical activity measured on the scalp and can
be collected non-invasively with relative ease and low
cost. Electroencephalography has strong predictive cap-
acity for outcome in the term infant with hypoxic
ischaemic encephalopathy [51]. Increasing use in the
preterm population, particularly in configurations using
a limited number of electrodes, are evidenced with the
first reports of its utility in predicting outcome [52, 53].
Multi-channel EEG, typically 10–20 channels in the
newborn, is well established in clinical practice and
provides information about normal and abnormal func-
tionality of the developing brain [54]. Deeper insights
are possible with further analysis of multichannel EEG
[55–58]. The power and the frequency of oscillations in
the cortex can be assessed using power spectral density
analysis [59].
Electroencephalography is able to define the elec-
trical activity of the neonatal brain structural net-
work that is visualised in diffusion imaging [30, 60,
61]. The electrical activity of these networks is char-
acterised by two alternating modes observed in the
amplitudes of EEG signals: a mode associated with
the self-organising, locally generated spontaneous
electrical activity transients (SATs) and a mode
representing the low-amplitude intervals between
SATs [62, 63]. This bimodality gradually attenuates
from mid gestation and activity becomes continous
by term [63].
In parallel to neuroimaging and neurophysiological
modalities, several clinical assessments of neuromotor,
neurobehaviour and neurological function are proposed
for use in the preterm period and early infancy [64].
Two systematic reviews on the clinimetric properties of
such measures found Prechtl’s General Movements As-
sessment to have the greatest predictive accuracy of an
outcome of CP [64, 65]. This neuromotor assessment
evaluates spontaneous infant movement from preterm
birth until 5 months CA [66]. A systematic review exam-
ining the accuracy of tests to predict CP included a meta-
analysis of GMs and reported a pooled sensitivity and spe-
cificity of 98 % (95 % CI 74–100 %) and 91 % (95 % CI
83–93 %) respectively [10]. It is important to note that
GMs at 3 months CA also predict severity of CP [67],
cognition [68], minor neurological dysfunction [69] and
behavioral and psychiatric outcome [70].
Neurobehaviour refers to an infant’s ability to self-
regulate, orientate, be responsive to stimuli and sustain
attention [71]. Neurobehavioural assessment in the pre-
term period reveals changes between birth and TEA,
and differences between preterm and term infants
assessed at TEA [72, 73]. Poorer neurobehavioural per-
formance at TEA is associated with white matter
abmormality on structural MRI, a range of adverse
perinatal variables and predicts neurodevelopmental
outcomes and CP at 18 months CA [72, 74, 75]. Com-
ponents of the NICU Neonatal Neurobehavioural Scale,
namely a low handling score, low movement score and
high lethargy score are significantly related to an
outcome of CP [75].
Neurological examination of infants offers reason-
able prediction of outcomes, with sensitivity and spe-
cificity increasing as the infant progresses from the
preterm period, through TEA and into the first year
of life [10, 76]. Prediction of CP and motor outcome
in the preterm period is relatively poor due to the pres-
ence of early transient abnormal signs with later good
outcomes causing false positives and the converse
resulting in false negatives [10, 77]. When neurological
examination is performed before term age in preterm
infants, the sensitivity for an outcome of CP is 57–86 %
and specificity 45–83 % [78, 79]. At term, neurological
assessment has a sensitivity of 88 % and specificity of
46 % to predict structural MRI abnormalities [80] and
68–79 % and 63–70 % to predict CP [78, 81]. In the post
term period sensitivity and specificity range from 68–96 %
and 52–97 % respectively [78, 81].
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Perinatal factors, including growth and nutrition, have
been identified as risk factors of adverse outcomes. Poor
growth during the first weeks after preterm birth is a sig-
nificant predictor of poor neurodevelopmental outcome
[82–84]. Increased nutrient intake leads to better growth
[85–87], and presumably better brain development, al-
though this relationship is not proven. There is a need for
clear evidence of the relationship between early nutrient
intake and brain development in preterm infants, so that
improved nutrient regimens can be designed.
Individual modalities of MRI, EEG, clinical measures,
perinatal risk factors and nutrition have been evaluated in
relation to later outcomes for preterm infants as described
above. Combinations of modalities have been evaluated
and often demonstrate improved prediction of outcomes
over individual modalities alone [7, 6, 10, 88, 89]. The rela-
tionships between modalities at TEA are emerging, but to
our knowledge, few studies to date have examined the re-
lationships between early clinical measures, perinatal risk
factors and nutrition, and very early imaging at 30 weeks
PMA [7, 15, 72, 73, 80, 90–92]. This study aims to con-
tribute to the understanding of brain structure-function
relationships in the very early phase of the developmen-
tal trajectory, improving the ability to identify infants at
risk of adverse outcomes, facilitating innovation of in-
terventions and developing quantitative biomarkers of
brain development.
Broad aim
This prospective cohort study of infants born ≤30 weeks
will investigate the relationship between brain structure
(structural and diffusion MRI), brain function (neurological,
neuromotor, neurobehaviour, vision and EEG), perinatal
risk factors and nutrition of very preterm infants in the pre-
term period (30–32 weeks) and at TEA; then examine the
ability of these early measures to predict motor and neuro-
developmental outcomes at 3 and 12 months CA.
Primary aims
In a prospective cohort study of infants born at ≤30 weeks,
and a term reference group, this study aims:
1. To examine the relationship between brain structure
on structural and diffusion MRI, brain function on
clinical measures of neurological, neuromotor and
neurobehavioural performance, and perinatal risk
factors at 30 and 40 weeks PMA.
2. To determine whether brain structure and function
at 30 weeks PMA predicts outcomes of brain
structure and function at 40 weeks PMA, 3 months
CA and 12 months CA.
3. To evaluate the ability of structural and diffusion
MRI and functional measures at 30 and 40 weeks
PMA age to predict motor outcome at 3 months CA
and motor, neurodevelopmental outcome and CP at
12 months CA.
4. To evaluate the ability of perinatal variables and social
risk (socio-economic status; SES) to predict severity of
motor outcome and CP at 12 months CA.
Secondary aims
1. To examine the development of motor, sensory,
visual and auditory connectivity between 30 week
and 40 week MRIs in infants born preterm with and
without brain lesions.
2. To examine the correlation between brain function
on dense array EEG, and motor and visual outcomes
at 40 weeks PMA.
3. To evaluate the ability of dense array EEG at 40 weeks
PMA to predict visual outcome at 3 months CA and
cognitive outcome at 12 months CA.
4. To examine the correlation between data fusion of
brain functions on dense array EEG and brain
structure on diffusion MRI, and motor and visual
outcomes at 40 weeks PMA.
5. To evaluate the ability of data fusion of brain
functions on dense array EEG and brain structure on
diffusion MRI, to predict visual outcome at 3 months
CA and cognitive outcome at 12 months CA.
6. To examine the relationship between preterm
macronutrient intake from birth to 34 weeks and
brain development at 40 weeks PMA, and determine
if nutritional intake is more predictive of brain
development than other maternal and neonatal risk
factors.
Hypotheses
The specific hypotheses to be tested include the follow-
ing. In infants born very preterm:
1. A strong correlation exists between MRI, clinical
measures and perinatal variables at 30 weeks PMA.
2. Brain structure and function at 30 weeks PMA
predicts outcomes at 40 weeks PMA, 3 months CA
and 12 months CA.
3. Brain structure and function at 40 weeks PMA predicts
neurodevelopmental outcome at 3 and 12 months CA.
4. A strong correlation exists between EEG, clinical
measures and perinatal variables at 40 weeks PMA,
and 3 months and 12 months CA.
Methods and analyses
Design
A prospective observational cohort study of infants born
very preterm with a comparison group of infants born at
term.
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Ethical considerations
Ethical permission to conduct the study has been obtained
from the Human Research Ethics Committees at The
Royal Brisbane & Women’s Hospital (HREC/12/QRBW/
245), and The University of Queensland (2012001060).
The trial has been registered with the Australian New
Zealand Clinical Trials Registry (ACTRN12613000280707).
Participation in the study is voluntary, written informed
consent for participation in the study is obtained from a
parent or guardian, and families may withdraw from the
study at any time without explanation.
Study sample and recruitment
Preterm sample
This study aims to recruit 80 preterm infants from the
Neonatal Intensive Care Unit (NICU) at the Royal
Brisbane and Women’s Hospital (RBWH). A research
nurse will screen infant admissions for eligibility, and de-
termine the appropriate stage to approach the family
based on medical stability and approval from the treat-
ing neonatologist. Eligible families will be approached
and if they express an interest in the study, they will be
provided with detailed information and an explanation
of the study. Parents will be given the opportunity to ask
questions and discuss involvement with their treating
clinician prior to making their decision. Informed writ-
ten consent will be obtained from parents or guardians
interested in participating and their infant will be for-
mally enrolled.
Inclusion criteria
Infants born at ≤30 week’s gestation, who live within
200 km of the hospital to allow for follow up hospital
appointments and home visits, and have English speak-
ing families as there is insufficient funding for transla-
tors, are eligible for this study.
Exclusion criteria
Infants diagnosed with any congenital or chromosomal
abnormality that could adversely impact neurodevelop-
mental outcome, and/or any contraindications to MRI,
are ineligible for this study.
Term reference sample
Twenty term born babies will be recruited from either
the postnatal ward of the RBWH, or as interested volun-
teers by word of mouth.
Eligibility criteria
Infants are eligible to participate in the reference sam-
ple if they are born between 38 and 41 weeks gestation
following an uncomplicated pregnancy and delivery,
have a birth weight above the 10th percentile, and are
not admitted to neonatal intensive or special care units
following their birth.
Sample size
There are no data currently available to assess the rela-
tionship between MRI and clinical measures at 30 weeks
PMA to predict motor outcome at 3 months CA and
motor/neurodevelopmental outcome or CP at 12 months
CA. Sample size calculations are based on a study inves-
tigating the ability of MRI at TEA, and the GMs assess-
ment, to predict motor outcomes and CP at 12 months
CA [6]. In a prospective cohort of infants born <30 weeks
GA and in a total sample size of n = 86, MRI was classified
as normal (n = 22), or with mild (n = 54), moderate (n = 6)
or severe (n = 4) white matter abnormality (WMA) [93].
Infants with normal or mild WMA were grouped (n = 76),
and infants with moderate and severe WMA were
grouped (n = 10) [6]. We assume the same ratio (7.6 MRI
normal or with mild/moderate WMA: 1 MRI with
moderate/severe WMA) will be observed in this study.
Of the n = 10 infants in the prior study that had moder-
ate/severe WMA, n = 5 (50 %) developed CP [6]. If we
assume that 5 % of infants with MRI normal or with mild/
moderate WMA develop CP, then the study requires 69
infants to be recruited (8 with MRI with moderate/severe
WMA and 61 with MRI normal or with mild/moderate
WMA) in order to be able to reject the null hypothesis
that the proportion of infants with CP in the two groups
are equal with power = 90 %. The Type I error probability
associated with this test of this null hypothesis is 0.05. In
order to explore WMA earlier, at 30 weeks PMA, and
its ability to predict CP at 12 months CA, an increase
in the projected numbers will be required, and a further
15–20 % added to account for attrition. Consequently,
the aim is to recruit a total sample size of 80 infants
with full data sets.
Perinatal data collection
An extensive record of the pregnancy, birth history, and
neonatal course will be collected from the medical dis-
charge summary. This will allow detailed description of
the characteristics of the sample, allow comparison to
outcomes establishing predictor variables, and to adjust
for confounders.
A number of prenatal variables have been shown to
impact short and long-term outcomes. Prolonged rup-
ture of membranes, defined as spontaneous rupture of
membranes ≥24 h before delivery is the most significant
risk factor of a poor outcome among pregnancy history
[94, 95]. Maternal antenatal corticosteroid administra-
tion reduces the risk of neonatal death and respiratory
distress (complete course defined as more than 1 dose
of steroids given, and 1st dose at more than 24 h and
less than 8 days before birth) [94–96]. Evidence also
George et al. BMC Pediatrics  (2015) 15:123 Page 5 of 17
exists for antenatal steroids protecting against cerebral
haemorrhage [97]. The neuroprotective effect of mag-
nesium sulphate administration reduces the risk of an
outcome of CP (relative risk 0.68, 95 % confidence
interval 0.54 to 0.87) [98]. Assisted conception is asso-
ciated with adverse neurodevelopmental outcomes in-
dependent of prematurity, multiple pregnancy and
gender for infants born between 22–26 weeks gestation
[99]. Multiple birth status will be examined as the
widely held view that singletons experience better out-
comes than multiples has recently been challenged. In a
population based study of n = 1473 born <29 weeks ges-
tation, infants from multiple gestation pregnancies
demonstrated comparable neurodevelopmental out-
comes to singletons [100].
Birth history variables collected will include GA at
birth, gender and birthweight. The risk of CP and ad-
verse neurodevelopmental outcomes increases with de-
creasing GA at birth [101] and multiple studies report
poorer outcomes for male infants [94, 102–104]. Intra
uterine growth retardation (IUGR) can result in de-
creased cortical volume, poorer outcomes and increased
risk of neonatal complications [105, 106] and babies that
are small for gestational age (SGA) are at a higher risk
of death, adverse neonatal outcomes and neurodevelop-
mental impairment [107]. Growth restriction in this
study will be defined as a birth weight <10th percentile
based on the Olsen growth curves.
Information will be gathered over each infant’s neo-
natal course from birth until discharge from hospital.
Cranial ultrasound findings, specifically findings of PVL
and IVH graded according to the criteria of Papile
et al., 1978 will be documented, with higher grades pre-
dictive of adverse outcomes and CP [108]. Necrotising
enterocolitis (NEC) is associated with poorer growth,
cognitive and motor outcomes and is considered
proven if the infant warranted treatment which in-
cluded nil by mouth and antibiotics [95, 109]. Late
onset sepsis is a significant risk factor, diagnosed by iso-
lation of an organism from at least one blood culture
and a decision to give antibiotics with therapeutic in-
tent, from 48 hrs after birth [94, 95]. Culture proven
sepsis is independently associated with an outcome of
CP [110]. Postnatal corticosteroid use demonstrates an
independent effect on poor outcome, in particular with
behavioural outcomes and CP [94, 111, 112]. Broncho-
pulmonary dysplasia or chronic neonatal lung disease
are independent risk factors for adverse neurodevelop-
mental outcomes due to recurrent episodes of hypoxia
[111, 113–117]. Chronic neonatal lung disease is de-
fined as babies born <32 weeks GA requiring any re-
spiratory support or supplemental oxygen for a chronic
pulmonary disorder at 36 weeks PMA [95]. Postmenstr-
ual age at NICU discharge will be documented, as
poorer behavioural outcomes are associated with longer
length of hospital stay [118].
For each infant from birth until 34 weeks PMA, the
daily intake of all nutrient-containing solutions will be
recorded. Intake of protein, lipid, carbohydrate and en-
ergy for each day will be calculated by multiplying intake
volumes for each solution administered by the nutrient
concentration obtained from manufacturers specifica-
tions or, for breast milk, published data [119].
Socio-demographic information such as maternal and
paternal education and occupation will be collected
using a baseline parent questionnaire (see Additional file 1).
Social and environmental factors may impact infant devel-
opment, and low socio-economic status and parenting fac-
tors have been shown to adversely influence outcomes
[120]. Social risk will be assessed using a score measuring
six aspects of social status including: family structure, edu-
cation of primary caregiver, occupation of primary income
earner, employment status of primary income earner, lan-
guage spoken at home and maternal age [116, 121, 122].
Each item will be scored between 0 and 2 for a total score
of 12, with scores of 2 and above being considered high
social risk in line with other research in this population
[121, 122]. Higher social risk has been strongly associated
with later behaviour problems, and independently predicts
a lack of early intervention services [122, 123]. A recent sys-
tematic review found evidence that lower socio-economic
status results in an additional risk of CP, over and above the
risks conferred by prematurity or lower birthweight [124].
Procedures
Study procedures are depicted in Fig. 1. Participants will be
recruited, consented and enrolled as described above. Be-
tween 30–32 weeks PMA, when medically stable, infants
will undergo an MRI. In the event an MRI cannot be
undertaken due to medical instability, MRI’s will be con-
ducted when the infant becomes medically stable and up
to a maximum age of 36 weeks PMA. This will ensure that
less fragile infants are not over-represented in the sample.
The following day, infants will undergo clinical assessment
by an assessor blinded to GA at birth, CUS and MRI find-
ings and any unrelated medical information, and a video
recording of their spontaneous movements will be cap-
tured. As there are no established gold standard neuro-
logical or neurobehavioural assessments for use at this
time point, a combination of the NICU Neonatal Neurobe-
havioural Scale (NNNS), Hammersmith Neonatal Neuro-
logical Examination (HNNE), and the Premie-Neuro will
be used [125]. These assessments will be combined to
minimise handling and modified to remove items unsuit-
able for administration at this age. The assessment time
will be 10–15 min, conducted before a scheduled feed and
cares to ensure optimum comfort and alertness. Infant
cues, physiological signs of stress or distress, oxygen
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saturations and heart rate will be monitored throughout,
and the assessment paused or discontinued where neces-
sary. The assessment will be video recorded for independ-
ent scoring and testing of inter- and intra-rater reliability.
At TEA the family will be invited to return for their
infant to undergo a second MRI and an EEG. The fol-
lowing day an assessor blinded to GA at birth and CUS
and MRI findings will visit the family at home to under-
take the clinical assessments. A video of the infant’s
spontaneous movement will be recorded for later
scoring of the GMs assessment, a brief assessment of
visual function will be undertaken and 3 motor and
neurobehavioural assessments will be administered,
combined to remove duplicate items. The NNNS as-
sessment, which is highly structured, will be com-
pleted first, followed by the few additional items of
the HNNE and the Test of Infant Motor Performance
(TIMP). Total assessment time will be approximately
1 h, however, the assessment will be conducted at the
infant’s pace, and breaks for feeds or sleep will be
undertaken as appropriate.
At 3 months CA, during a home visit, a GMs video
of the infant’s spontaneous movement will be taken,
and a visual assessment and the TIMP will be com-
pleted. The total assessment time will be approxi-
mately 40 min.
At 12 months CA, families will be invited back to the
RBWH for follow up assessment of their child’s motor
and neurodevelopmental outcome. In a telephone call
prior to the appointment a research nurse will gather up
to date information on the child’s current medical team,
medical history since discharge, any diagnoses made and
details of any interventions they have received. A paedia-
trician blinded to medical history will assess for signs of
neurological abnormality and the presence of features of
CP. A physiotherapist blinded to background history will
conduct neurodevelopmental and motor assessments. As
no single measure has been shown to provide conclusive
data on attainment and quality of motor skills in this
population, a combination of the Bayley Scales of Infant
and Toddler Development III (Bayley III), the Neurosen-
sory Motor Developmental Assessment (NSMDA) and
the Alberta Infant Motor Scale (AIMS) will be performed




Brain MRI will be performed using a 3T (Siemens Tim
Trio, Erlangen, Germany) and an MR compatible incu-
bator with dedicated neonatal head coil (LMT Lammers
Medical Technology, Lubeck, Germany). Noise from the
Fig. 1 Consort Flowchart of PPREMO Study Procedure
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MRI will be attenuated using Natus Mini Muffs (Natus
Medical Inc., San Carlos, CA). The preterm group will
have an MRI at 30–32 and again at 40–42 weeks PMA.
The term group will have an MRI at 40–42 weeks PMA.
All infants will be monitored with pulse oximetry and
electrocardiographic monitoring. Infants will be fed, fitted
with ear protection to minimize noise exposure, carefully
wrapped and placed in the incubator in the scanner with-
out sedation or anaesthesia. The total scanning duration
will be approximately 45–60 min for each baby. Where
possible, images impacted by significant motion artefacts
will be rescanned. The MR protocol will include T1, T2
TSE, T1w MPRage, T2w HASTE and 3 echo T2 map,
Arterial Spin Labelling (ASL), 30 direction diffusion
weighted imaging (DWI), and 64 direction DWI se-
quences. Additional file 2 outlines the MRI protocol pa-
rameters. A neuroradiologist will review clinical sequences
and classify white and grey matter injury [93, 127].
Quantitative T2 will be measured using a T2 image
series acquired with echo times of 27, 122 and 189 ms and
repetition time 10580 ms; 47 axial contiguous slices of
2.0 mm thickness will be acquired with a 144 × 180 mm
field of view, a flip angle of 150°, and a 153 × 256 matrix
(reconstructed to 204 × 256), resulting in voxel sizes of
0.70 × 0.70 × 2.0 mm3. T1-weighted magnetization pre-
pared rapid-acquisition gradient echo volumes in the
sagittal plane will be acquired with an echo time of
3.21 ms and repetition time 2100 ms; 96 sagittal slices of
1.3 mm thickness will be acquired with a 160 mm field of
view, a flip angle of 9°, and a 128 × 128 matrix, resulting in
voxel sizes of 1.25 × 1.25 × 1.3 mm3.
Diffusion images will be acquired using single-shot
echo planar multi-direction diffusion-weighted sequence,
employing dual bipolar diffusion gradient and double spin.
This will include the acquisition of a 30 direction DWI
protocol (b = 1000 s/mm2) and a 64 direction HARDI
protocol (b = 2000 s/mm2). The images will be acquired
per location, consisting of one low (b = 0 s/mm2) and the
rest high (b = 1000 or 2000 s/mm2) diffusion-weighted im-
ages, in which the encoding gradients are uniformly dis-
tributed in space. Imaging parameters of the diffusion
sequence will be: field of view 224 × 224 mm, matrix
128 × 128, repetition time 9500 ms, echo time 130 ms and
flip angle of 90°. A field map for diffusion data is acquired
using two 2D gradient recalled echo images (TE1/TE2 4.9/
7.4 ms) to assist in correction for residual distortions due
to susceptibility inhomogeneity’s (acquisition time 1 m).
These sequences allow exploration of brain microstruc-
ture and function, specifically: (i) regional and global
cortical surface and thickness, (ii) white matter organ-
isation, (iii) structural connectivity of relevant areas
and (iv) pre-myelination (T2).
Arterial spin labelling MRI provides a non-invasive
technique to measure cerebral blood flow (CBF),
although its feasibility and value in neonates is largely
unknown. As the neonate’s brain rapidly grows, it is an-
ticipated that an associated increase in CBF would occur
to supply the nutrients and energy needed for the added
brain weight [128]. Arterial spin labelling MRI will be
performed using a PICORE Q2TIPS sequence with
echo-planar imaging. Imaging parameters of the ASL
scan will be: field of view 256 mm, matrix 64 × 64, repe-
tition time 3427.5 ms, echo time 21 ms, inversion time
of arterial spins (TI1) 700 ms, saturation stop time
1600 ms, total transit time of the spins (TI2) 1800 ms,
tag thickness 100 mm, tag to proximal slice gap 25 mm,
17 axial slices, slice thickness 5 mm, time lag between
slices 22.5 ms, and Bandwidth Per Pixel Phase Encoding
time of 23.343 ms.
Image analysis
MRI data will be analysed using advanced image pro-
cessing techniques as below.
a) Structural Analysis
T2 relaxation maps will be obtained from
three T2-weighted images by first aligning all
T2- weighted images to the T2-weighted image
with the shortest echo time (TE = 27 ms) using
rigid-body registration, followed by voxel-wise
estimation of T2 employing a nonlinear least-
squares fit. The T2w MR will be segmented
using the MILXView neuroimaging platform
with the UNC neonate atlas and ALBERT atlas
used to provide initial priors and anatomical
labelling [129–131]. Statistical analysis will use
Regions-of-Interest and voxel based analysis
techniques. Summary measures of T2 will be
calculated within pathways delineated using
tractography.
b) Diffusion Analysis
An extensive pre-processing and quality
control procedure will be used to detect and
correct image artefacts caused by involuntary
head movement, cardiac pulsation, and image
distortions [30]. Fractional anisotropy (FA) and
mean diffusivity (MD) will be estimated from
corrected diffusion data using a diffusion tensor
model. Constrained spherical deconvolution
implemented in MRtrix will be employed to
estimate fibre orientation distribution (FOD)
[132]. Whole-brain voxel based analysis of FA
and MD will be performed using tract-based
spatial statistics optimised for neonates [133].
Whole-brain voxel-based analysis of fibre orien-
tation distributions will be conducted using
Apparent Fibre Density (AFD) [31]. Probabilistic
tractography will be performed using MRtrix.
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White matter pathways will be delineated
using the multi-regions-of-interest approach.
A number of pathways, including cortico-spinal
tract, corpus callosum, superior longitudinal
fasciculus and thalamic radiations, will be
extracted. Summary measures of FA, MD, AFD
and T2 within pathways will be calculated.
c) Arterial Spin Labelling analysis
An extensive pre-processing and quality control
procedure will be used to detect and correct image
artefacts caused by motion, random thermal and
physiological noise, EPI distortion, spatial-
temporal denoising, correction for temporal decay
and partial voluming of the signal. The CBF maps
will then be calculated in absolute units ml100g 60s
 
,
with the first equilibrium magnetization of arterial
blood estimated using the calibration image (first
acquired image), and GM and WM maps rescaled.
Statistical analysis will use Regions-of-Interest and
voxel based analysis techniques.
EEG
Dense array EEG (dEEG) will be collected using either;
i) a NicOne EEG amplifier (Cardinal Healthcare, USA)
with a sampling rate of 256 Hz from 32 channels using
an appropriately sized EEG cap (Waveguard, ANT-
Neuro, Germany) with electrode positioning according
to the international 10–20 standard, or ii) a 64-electrode
high-density sensor net (HydroCel Geodesic Sensor Net,
Electrical Geodesics Inc.). Each electrode is enclosed in
a saline sponge, in a geodesic tension structure com-
prised of elastic threads EEG signals are transmitted
from the sensor net electrodes to an amplifier (Electrical
Geodesics Inc.) digitised and recorded via NetStation
software (Electrical Geodesics Inc.).
For the EEG data i) directional relationships between
channels, ii) frequency-specific amplitude fluctuations, and
iii) time-varying behaviour through directional connectivity
analysis and phase synchrony among channels will be ex-
amined. Electroencephalography power will be estimated in
the frequency bands delta/theta (2–7 Hz), alpha (8–13 Hz),
beta (14–32 Hz) to examine changes in the power and fre-
quency of oscillations over the sensorimotor cortex as an
index of corticospinal linkage and maturation [59].
The electric resting state network (eRSN) analysis
will follow a multi-step procedure comprising i) pre-
processing of EEG signals, ii) extracting band ampli-
tude fluctuation envelopes at the frequency band of
interest, and iii) evaluating their network characteristics
within two modes of activity. Relationships between
eRSN characteristics and outcome will be sought using
approaches including pair-wise relationships such as
mutual information measures, with testing using
surrogate signals as well as different statistical testings
at individual and group levels.
Clinical measures
General Movements Assessment (GMs)
The GMs is a predictive and discriminative tool that
involves observation of an infant’s spontaneous motor
activity [66]. It can be used from preterm birth until
20 weeks CA and is carried out by videoing the infant in
supine, in a calm alert state with no external stimulation.
Scoring is completed from the recording with 3 full
movement sequences required for pattern recognition
(approximately 5 min) [66]. In the early preterm stage
this may require up to an hour of video in order to se-
lect sequences of active movement, but at TEA and
12 weeks CA it may only take a few minutes. Move-
ments are classified as normal or abnormal (poor reper-
toire, cramped synchronised or chaotic) in the writhing
period from preterm up to 6 weeks post term. During
the fidgety period from 9–20 weeks post term, fidgety
movements are classified as present, abnormal or absent
[66]. Infants in this study will have an assessment of
their GMs in the preterm period (30–32 weeks PMA),
one assessment at TEA, and one at 10–12 weeks CA.
The GMs have been found to have the greatest predict-
ive accuracy of motor outcome in two systematic re-
views on the clinimetric properties of neuromotor and
neurobehavioural assessment tools for use in preterm in-
fants in the preterm period and first year of life [64, 65].
A systematic review examining the accuracy of tests to
predict cerebral palsy included a meta-analysis of GMs.
The pooled sensitivity and specificity were 98 % (95 %
CI 73–100 %) and 91 % (95 % CI 83–95 %) respectively
[10]. General Movements in the fidgety period display
greater sensitivity and specificity than those in the writh-
ing period [6, 7, 134] and have also shown an ability to
predict functional severity of CP as classified by GMFCS
[67]. Additionally, GMs predict cognition [68, 135, 136],
minor neurological dysfunction and developmental co-
ordination disorder [69, 137], as well as behavioral and
psychiatric outcomes [70, 138].
The NICU Network Neurobehavioural Scale (NNNS)
The NNNS is a discriminative neurobehavioural assess-
ment initially designed for use in prenatally substance
exposed infants as part of the Maternal Lifestyle Study
(MLS) [139]. It’s application for use in other high-risk
infant populations including very preterm infants is now
well established [64, 75, 125]. Neurobehavioural func-
tioning is determined through evaluation of neurological
and motor performance, orientation to auditory and
visual stimuli, state regulation, self-soothing competence
and stress signs. Forty-five items are administrated in a
structured format comprising state-dependent ‘packages’,
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with a further 21 summary items scored. The stress/abstin-
ence scale encompasses an additional 51 observed items.
Summary scores are calculated to enable statistical analysis,
and they include orientation, habituation, hypertonicity,
hypotonicity, excitability, arousal, lethargy, nonoptimal re-
flexes, asymmetric reflexes, stress, self-regulation quality of
movement and handling [140]. Training and certification is
required to administer and score the assessment.
Normative data on the NNNS are available in 2 stud-
ies, with samples of 125 and 344 healthy term infants re-
spectively, assessed within 48 h of birth [141, 142]. Data
of preterm infants assessed using the NNNS at 1 month
CA are available though it is important to note that the
cohort is selected from the MLS sample and therefore
includes infants with high social risk and drug-exposure
[143]. Preterm infants display poorer neurobehaviour at
TEA when compared to term controls on the NNNS
[144, 73]. Significant disturbances were found in motor
behaviour, tone, poorer self-regulation capacities,
higher excitability scores [144], poorer orientation,
lower tolerance of handling and more stress in preterm
infants compared with term born infants [73]. These al-
terations in neurobehaviour correlated with cerebral
abnormalities in white and grey matter on qualitative
structural MRI [72]. Predictive validity of the NNNS
has been established with neurobehaviour at term pre-
dicting motor and cognitive outcomes at 18 months,
motor outcomes at 24 months and cognitive outcomes
at 4.5 years [75, 145, 146]. Test-retest reliability has
been established with preterm infants with correlations
ranging from .30 to .44 across three time points tested
(34, 40 and 44 weeks PMA) [147].
Hammersmith Neonatal Neurological Examination (HNNE)
The HNNE was developed for the assessment of term
and preterm infants at risk of developmental delay
[148–150]. It is a discriminative and predictive test that
assesses posture and tone, reflexes, movements and neu-
robehavioural responses. It is criterion and norm refer-
enced, with normative data from a sample of 224
healthy low-risk term infants assessed between 6 and
48 h after birth [149]. Raw scores are converted into a
continuous score derived through optimality scoring
with final scores ranging between 0–34, and scores
<30.5 considered to be suboptimal [150]. Preterm infants
have been found to have poorer scores on the HNNE
compared with term born infants when assessed at TEA.
In a sample of 157 infants born at <33 weeks GA mean
optimality scores were 26.4 [151]. Discriminative validity
was demonstrated in a normative study of a sample of
380 preterm infants (GA at birth 25–35 weeks) with a
normal outcome and a sample of 85 infants who devel-
oped CP examined at TEA. Preterm infants with later
outcome of CP had a greater number of suboptimal
items scored compared to those preterm infants who
had a normal outcome [152]. Concurrent validity has
been demonstrated in 2 studies (n = 168 and n = 66),
where poorer scores on the HNNE related to increasing
severity of cerebral abnormality on structural MRI [72, 80].
A systematic review examining the predictive validity of
the HNNE to predict an outcome of CP report a sensitivity
range of 57–86 % and specificity range of 45–83 % when
performed before term age (<37 weeks PMA) [78, 79]. This
increases to a sensitivity range of 68–96 % and specificity
range of 52–97 % when assessed in the post term period
[78, 81]. Percentage agreement has been shown to be good
between raters after training (>96 %) [153], however few
reliability statistics are available. The infants in the present
study will have the HNNE assessment at 30 weeks gesta-
tion, and TEA.
Premie-neuro
The Premie-Neuro is a neurological and neurobeha-
vioural assessment tool developed by Ellison and Daily
[154]. It consists of 3 subscales of 8 items each: neuro-
logic, movement and responsiveness. Although limited
published data are available for this relatively new tool,
it was selected for this study for the following reasons: i)
scoring of neurologic and movement subscales can be
completed in even the sickest and most fragile of infants
as they require minimal handling, ii) significant overlap
with the HNNE and NNNS means the assessment can
be scored with the addition of only 2 items overall, iii)
scores are based on expected findings at differing gesta-
tional age [154]. Validity has been established for dis-
criminating between preterm infants at high and low
risk for neurodevelopmental delay, although interrater
reliability was low and test–retest reliability was fair to
moderate [155]. It will be scored from the combined
assessment performed at 30 weeks PMA for infants in
this study.
Neonatal visual assessment
The neonatal assessment of visual functions provides
useful information on various aspects of early neonatal
visual function, including ocular motility, fixation, fol-
lowing, acuity and attention at distance. The battery is
easy to perform, does not require long training, and can
be performed reliably from 32 weeks PMA [156]. It has
been demonstrated to contribute to prediction of neuro-
developmental outcome in preterm babies [157–159].
The overall sensitivity and specificity of Neonatal Visual
Assessment to predict 12 month CA visual scores were
90 % and 63 % respectively in 121 preterm infants [158].
In this study, infants will be assessed at TEA and
12 weeks CA.
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Test of Infant Motor Performance (TIMP)
The TIMP is a discriminative and evaluative test of func-
tional motor behaviour used to assess infants between
the ages of 34 weeks PMA and 4 months CA [160, 161].
The test assesses the postural and selective control of
movement needed for functional motor performance in
early infancy and is norm referenced. Observational and
elicited items are administered in a standardised proced-
ure and the test takes 20–40 min to administer. At
12 weeks CA, the TIMP has been shown to predict
12 month motor performance with sensitivity 92 % and
specificity 76 % [162] and preschool motor performance
(mean age 4.75 years) with sensitivity 72 % and specifi-
city 91 % [163]. In this study, the TIMP will be per-
formed at TEA, and at 12 weeks CA by an assessor
trained by the test author.
Neurodevelopmental and motor outcome at 12 months
Medical assessment
A paediatrician experienced in infant development and
diagnosis of CP will independently assess infants in this
study at 12 months CA. The purpose of this assessment
is to discriminate which infants are developing typically
from those who are not, and to confirm diagnoses of CP
or not CP [164]. It is acknowledged that 12 months CA
is early to confirm a diagnosis of CP, especially in less
severe cases. For this reason a structured neurological
examination of posture, reflexes, muscle tone and move-
ment will be conducted with participants classified as
‘normal’ (entirely normal neurological examination), ‘un-
specified signs’ (e.g. hypotonia, asymmetric reflexes) or
‘abnormal’ (definite neurological abnormality, likely CP).
In cases where CP can be confirmed, motor type and
distribution will be recorded as per the SCPE guidelines
[165], and functional severity established through classi-
fication with the Gross Motor Function Classification
System (GMFCS) [166]. The assessment will be videoed
and a second blinded assessor will perform this classifi-
cation for reliability purposes.
Bayley Scales of Infant and Toddler Development III (Bayley III)
The Bayley III is a discriminative tool designed to assess
cognitive, language and motor development, and social-
emotional and adaptive behaviour [167]. It is currently
the most widely used assessment tool for overall neuro-
development in follow up studies of preterm infants be-
tween 1 and 3 years CA. It is a norm-referenced test
with normative data for the cognitive, language and
motor subscales taken from a sample of 1700 American
infants and children [167]. Normative data for the
adaptive behaviour scale was obtained independently in
a sample of 1350 infants and children [167]. Normed
scores of the Bayley III have a mean of 100 and a stand-
ard deviation of 15, where higher scores reflect better
development. The Bayley III motor composite score
correlates with the second edition of the Peabody De-
velopmental Motor Skills (r =0.57) [167]. Reliability has
been established with the average reliability coefficients
for the composite scale scores ranging from .91 (Cogni-
tive) to .93 (Language) [167]. In a systematic review of the
predictive value of the Bayley III on development of very
preterm infants, mental development index scores were
strongly predictive of later cognitive functioning (14
studies with a total sample n = 1330 children), r = 0.61
(95 % CI: 0.57–0.64) [168]. Motor scale scores were
only moderately predictive of later motor function
(across 5 studies with a total sample of n = 555 children),
r = 0.34 (95 % CI: 0.26–0.42). For this reason, a further
two assessments which are primarily motor assessments,
and have stronger psychometric properties will be used,
the NSMDA and the AIMS [65]. The Bayley III involves
interaction between the infant and the examiner in a stan-
dardised series of play tasks, and takes 45–60 min to ad-
minister at 12 months CA.
Neurosensory Motor Developmental Assessment (NSMDA)
The NSMDA is a discriminative and predictive, criterion-
referenced test of gross and fine motor development
[65, 169]. It examines gross and fine motor performance,
neurological status, posture, balance and response to sen-
sory input. The examiner observes and administers items
and the test takes 10–30 min to complete. The results give
a total score and a functional classification of motor devel-
opment as normal, or with mild, moderate or severe
problems of posture, movement and co-ordination. As-
sessment at 4 months predicts outcomes at 24 months
with a sensitivity of 80 % and a specificity of 56 % [170].
Studies looking at the longer term predictive validity of
the NSMDA, found assessment at 12 months had strong
associations with motor and cognitive scores at 4 years
[171], and NSMDA assessment at 8 months to have an 80
% sensitivity of motor outcomes at 11–13 years in ex-
tremely low birth weight infants with no apparent neuro-
logical deficit or CP [172]. The NSDMA will be used to
classify each infant’s development as normal or as having
mild, moderate, severe or profound motor dysfunction at
12 months CA.
Alberta Infant Motor Scale (AIMS)
The AIMS is a discriminative, norm-referenced tool
that tests gross motor skills through the components of
weight bearing, posture and antigravity movements
[162, 173]. The test involves observation of the infant
in prone, supine, sitting and standing and is able to be
completed in this study purely through observation
during the Bayley III and NSMDA assessments with no
additional handling. Normative data are based on a
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population of 2200 term infants from 0–18 months in
Alberta, Canada [174], and when recently compared
with a contemporary sample of 650 Canadian infants,
found to still be relevant. Normative data for preterm
infants has also been published with a sample of 800 in-
fants born at ≤32 weeks from the Netherlands [175].
Raw scores are obtained with centile ranks and age equiva-
lent growth scores available for term and preterm infants.
The AIMS has high inter-rater reliability (ICC = .98 to .99)
[176, 177], and intra-rater reliability (ICC = .97-.99) [177].
Concurrent validity with the Bayley II at 12 months CA in
a cohort of preterm infants has been established (r = .90)
[177]. Although the AIMS was not designed as a predictive
tool, it has moderate to excellent predictive validity. In a
sample of 164 preterm infants assessed at 8 months CA,
the AIMS predicted motor outcomes at 18 months CA
with a sensitivity 86.4 % and specificity 93 % [178]. The
suitability of using the AIMS as a discriminative and pre-
dictive tool at 12 months CA in preterm infants has been
supported by a clinimetric review of neuromotor measures
for preterm infants in the first year of life [65]. The AIMS
will be used to classify each infant’s development as normal
or suspicious/abnormal at 12 months CA in this study.
Blinding
The researchers involved in MRI and EEG analysis
(KP, JF, SER, MML, AHTK) will be blinded to GA at
birth, CUS findings and clinical assessment findings.
The researchers carrying out the clinical assessments
and scoring (JMG, PBC) will be blinded to gestational
age at birth, MRI and CUS findings. Outcome assess-
ments at 12 months CA will be performed and scored
by assessors blinded to infant perinatal history, MRI
and early clinical assessment findings.
Adverse events
There are no known health or safety risks related to any
aspect of the described study. There are no known risks
for MRI and no sedation will be used. The principal
researchers RNB, PBC and SER will review any adverse
event or unintended effect detected.
Data analysis and statistical considerations
When models involve brain structure and function data
from one time point (either 30–32 or 40–42 weeks),
standard regression models will be constructed; when
models use data from both 30–32 and 40–42 weeks,
mixed-effects models that take into account within-
infant correlation will be used. Models will be constructed
using standard principles; first univariable analyses will be
used to identify variables significant at the p < 0.15 level
and these variables then entered into multivariable models
one-by-one, in decreasing order of significance. At each
step the current model will be compared to previous
models using the likelihood ratio test. Linear regression will
be used for continuous outcomes (e.g. diffusion MRI mea-
sures of FA and MD); logistic regression for binary out-
comes (e.g. disability/no disability); and multinomial logistic
regression for categorical outcomes with > 2 categories (e.g.
NSMDA categories of normal/suspect/abnormal). Results
will be presented as effect estimates and 95 % confi-
dence intervals. The sensitivity and specificity of the
predictive assessment model will be determined based
on diagnosis of disability using standard definitions.
Perinatal, clinical, demographic and social characteris-
tics will be included as covariables when appropriate.
Analyses will be supervised by RSW, a senior biostatis-
tician at The University of Queensland.
Discussion
To our knowledge, this protocol describes the first study
examining the clinical correlates of early advanced brain
imaging and clinical measures at 30 weeks PMA to pre-
dict motor and neurodevelopmental outcomes at 3 and
12 months CA.
The results of this study will i) establish the relation-
ships between early clinical measures, EEG, perinatal
variables and nutrition and early advanced neuroimaging
at 30 weeks PMA, ii) establish which components of
brain structure and function most accurately predict
neurodevelopmental, motor outcomes and CP at 3 and
12 months CA, iii) accurately identify infants at risk of
adverse outcomes at an earlier stage, introducing an
additional window of opportunity for intervention, iv)
contribute to understanding brain development between
30 and 40 weeks PMA, v) and develop robust quantita-
tive biomarkers of brain maturation, which can then be
used in the research of interventions in this population.
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